{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:41:10Z","timestamp":1791420070379,"version":"4.3.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06018-1","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T13:02:44Z","timestamp":1724072564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK\u00ae3 study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8369-1553","authenticated-orcid":false,"given":"Dilek","family":"\u00d6r\u00fcm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4154-0738","authenticated-orcid":false,"given":"Mehmet Hamdi","family":"\u00d6r\u00fcm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-9426","authenticated-orcid":false,"given":"Ya\u015far","family":"Kap\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-4970","authenticated-orcid":false,"given":"Sabri","family":"Abu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"6018_CR1","unstructured":"Cardiovascular diseases, World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Available 6\/12\/2024."},{"key":"6018_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"6018_CR3","unstructured":"World Drug Report 2023, United Nations Office on Drugs and Crime. World Drug Report 2023 (unodc.org). Available 6\/12\/2024."},{"key":"6018_CR4","doi-asserted-by":"publisher","first-page":"676850","DOI":"10.3389\/fcvm.2021.676850","volume":"8","author":"J Zhao","year":"2021","unstructured":"Zhao J, Chen H, Zhuo C, Xia S. Cannabis use and the risk of cardiovascular diseases: a mendelian randomization study. Front Cardiovasc Med. 2021;8:676850.","journal-title":"Front Cardiovasc Med"},{"key":"6018_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ehf2.12572","volume":"7","author":"V Schwarzbach","year":"2020","unstructured":"Schwarzbach V, Lenk K, Laufs U. Methamphetamine-related cardiovascular diseases. ESC Heart Fail. 2020;7:407\u201314.","journal-title":"ESC Heart Fail"},{"key":"6018_CR6","doi-asserted-by":"publisher","first-page":"e023663","DOI":"10.1161\/JAHA.121.023663","volume":"11","author":"L Curran","year":"2022","unstructured":"Curran L, Nah G, Marcus GM, Tseng Z, Crawford MH, Parikh NI. Clinical correlates and outcomes of methamphetamine-associated cardiovascular diseases in hospitalized patients in California. J Am Heart Assoc. 2022;11:e023663.","journal-title":"J Am Heart Assoc"},{"key":"6018_CR7","doi-asserted-by":"crossref","unstructured":"Camfield K, Reedy A, Wolf C, Al-Tayyib A, Rinehart D, Simpson SA, et al. Diagnosis of methamphetamine-induced psychotic disorder: findings of an expert consensus panel. Early Interv Psychiatry; 2024.","DOI":"10.1111\/eip.13547"},{"key":"6018_CR8","first-page":"231","volume":"60","author":"Y Kap\u0131c\u0131","year":"2023","unstructured":"Kap\u0131c\u0131 Y, G\u00fcc B, Tekin A, Abu\u015f S. The relationship of ten-year cardiovascular disease risk and clinical features in patients with schizophrenia. Noro Psikiyatr Ars. 2023;60:231\u20135.","journal-title":"Noro Psikiyatr Ars"},{"key":"6018_CR9","doi-asserted-by":"crossref","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 2017;357:j2099.","DOI":"10.1136\/bmj.j2099"},{"key":"6018_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1037\/pha0000258","volume":"27","author":"MJ De Vita","year":"2019","unstructured":"De Vita MJ, Maisto SA, Ansell EB, Zale EL, Ditre JW. Pack-years of tobacco cigarette smoking as a predictor of spontaneous pain reporting and experimental pain reactivity. Exp Clin Psychopharmacol. 2019;27:552\u201360.","journal-title":"Exp Clin Psychopharmacol"},{"key":"6018_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/002204260503500203","volume":"35","author":"JE Schulenberg","year":"2005","unstructured":"Schulenberg JE, Merline AC, Johnston LD, O\u2019Malley PM, Bachman JG, Laetz VB. Trajectories of marijuana use during the transition to adulthood: the big picture based on national panel data. J Drug Issues. 2005;35:255\u201379.","journal-title":"J Drug Issues"},{"key":"6018_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285\u201394.","journal-title":"Arch Med Res"},{"key":"6018_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lfs.2014.02.033","volume":"102","author":"HO Vargas","year":"2014","unstructured":"Vargas HO, Nunes SO, Barbosa DS, Vargas MM, Cestari A, Dodd S, et al. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 2014;102:65\u201371.","journal-title":"Life Sci"},{"issue":"1","key":"6018_CR14","first-page":"51","volume":"30","author":"M Elbir","year":"2019","unstructured":"Elbir M, Alp Topba\u015f \u00d6, Bayad S, Kocaba\u015f T, Topak OZ, \u00c7etin \u015e, et al. Adaptation and reliability of the structured clinical interview for DSM-5-Disorders - Clinician Version (SCID-5\/CV) to the Turkish language. Turk Psikiyatri Derg. 2019;30(1):51\u20136. Turkish.","journal-title":"Turk Psikiyatri Derg"},{"key":"6018_CR15","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders, 5th edition, text revision.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"6018_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4172\/2155-6105.1000324","volume":"8","author":"S Kumari","year":"2017","unstructured":"Kumari S, Malik M, Florival C, Manalai P, Sonje S. An assessment of five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS). J Addict Res Ther. 2017;8:324.","journal-title":"J Addict Res Ther"},{"key":"6018_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1192\/bjp.156.6.798","volume":"156","author":"AS David","year":"1990","unstructured":"David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798\u2013808.","journal-title":"Br J Psychiatry"},{"key":"6018_CR18","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1360-0443.2002.00162.x","volume":"97","author":"KP Richter","year":"2002","unstructured":"Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002;97:861\u20139.","journal-title":"Addiction"},{"issue":"10","key":"6018_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"6018_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/euhj.1998.1194","volume":"20","author":"JF Price","year":"1999","unstructured":"Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery study. Eur Heart J. 1999;20:344\u201353.","journal-title":"Eur Heart J"},{"key":"6018_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/neurolint14010015","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Thompson E, Merriman CE, Alvarez MR, Alpaugh ES, Cornett EM, et al. Oxytocin, a novel treatment for methamphetamine use disorder. Neurol Int. 2022;14:186\u201398.","journal-title":"Neurol Int"},{"key":"6018_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40263-014-0209-8","volume":"28","author":"S Glasner-Edwards","year":"2014","unstructured":"Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014;28:1115\u201326.","journal-title":"CNS Drugs"},{"issue":"6","key":"6018_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/met.2023.0003","volume":"21","author":"PS Akinola","year":"2023","unstructured":"Akinola PS, Tardif I, Leclerc J. Antipsychotic-induced metabolic syndrome: a review. Metab Syndr Relat Disord. 2023;21(6):294\u2013305.","journal-title":"Metab Syndr Relat Disord"},{"key":"6018_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/ph14030238","volume":"14","author":"M Carli","year":"2021","unstructured":"Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, et al. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals (Basel). 2021;14:238.","journal-title":"Pharmaceuticals (Basel)"},{"key":"6018_CR25","first-page":"21","volume":"23","author":"J Yogaratnam","year":"2013","unstructured":"Yogaratnam J, Biswas N, Vadivel R, Jacob R. Metabolic complications of schizophrenia and antipsychotic medications\u2013an updated review. East Asian Arch Psychiatry. 2013;23:21\u20138.","journal-title":"East Asian Arch Psychiatry"},{"key":"6018_CR26","doi-asserted-by":"publisher","first-page":"e6631","DOI":"10.1097\/MD.0000000000006631","volume":"96","author":"M Zhang","year":"2017","unstructured":"Zhang M, Lv D, Zhou W, Ji L, Zhou B, Chen H, et al. The levels of triglyceride and total cholesterol in methamphetamine dependence. Med (Baltim). 2017;96:e6631.","journal-title":"Med (Baltim)"},{"key":"6018_CR27","doi-asserted-by":"publisher","first-page":"j1340","DOI":"10.1136\/bmj.j1340","volume":"356","author":"K Mukamal","year":"2017","unstructured":"Mukamal K, Lazo M. Alcohol and cardiovascular disease. BMJ. 2017;356:j1340.","journal-title":"BMJ"},{"key":"6018_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2005.12.003","volume":"84","author":"SH Rhee","year":"2006","unstructured":"Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Neale MC, et al. Comorbidity between alcohol dependence and illicit drug dependence in adolescents with antisocial behavior and matched controls. Drug Alcohol Depend. 2006;84:85\u201392.","journal-title":"Drug Alcohol Depend"},{"key":"6018_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1521\/suli.2010.40.1.50","volume":"40","author":"E Maloney","year":"2010","unstructured":"Maloney E, Degenhardt L, Darke S, Nelson EC. Investigating the co-occurrence of self-mutilation and suicide attempts among opioid-dependent individuals. Suicide Life Threat Behav. 2010;40:50\u201362.","journal-title":"Suicide Life Threat Behav"},{"key":"6018_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/brainsci13091279","volume":"13","author":"A Al-Imam","year":"2023","unstructured":"Al-Imam A, Motyka MA, Hoffmann B, Al-Ka\u2019aby H, Younus M, Al-Hemiary N, et al. Risk factors of suicidal ideation in Iraqi crystal methamphetamine users. Brain Sci. 2023;13:1279.","journal-title":"Brain Sci"},{"key":"6018_CR31","first-page":"146","volume":"6","author":"SR Radfar","year":"2014","unstructured":"Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addict Health. 2014;6:146\u201354.","journal-title":"Addict Health"},{"key":"6018_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4088\/JCP.09m05360gry","volume":"72","author":"CJ Kuo","year":"2011","unstructured":"Kuo CJ, Tsai SY, Liao YT, Conwell Y, Lin SK, Chang CL, et al. Risk and protective factors for suicide among patients with methamphetamine dependence: a nested case-control study. J Clin Psychiatry. 2011;72:487\u201393.","journal-title":"J Clin Psychiatry"},{"key":"6018_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1039856218810155","volume":"27","author":"A Unadkat","year":"2019","unstructured":"Unadkat A, Subasinghe S, Harvey RJ, Castle DJ. Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications? Australas Psychiatry. 2019;27:14\u20137.","journal-title":"Australas Psychiatry"},{"key":"6018_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/10550490802019816","volume":"17","author":"R McKetin","year":"2008","unstructured":"McKetin R, McLaren J, Lubman DI, Hides L. Hostility among methamphetamine users experiencing psychotic symptoms. Am J Addict. 2008;17:235\u201340.","journal-title":"Am J Addict"},{"key":"6018_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.30773\/pi.2023.0199","volume":"21","author":"N G\u00fcrb\u00fczer","year":"2024","unstructured":"G\u00fcrb\u00fczer N, G\u00fcler MC, T\u00f6r IBH. Methamphetamine use disorder and inflammation: a case-control study. Psychiatry Investig. 2024;21:513\u201320.","journal-title":"Psychiatry Investig"},{"key":"6018_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.9758\/cpn.22.1047","volume":"21","author":"\u00c7 Turan","year":"2023","unstructured":"Turan \u00c7, \u015eenormanc\u0131 G, Ne\u015felio\u011flu S, Budak Y, Erel \u00d6, \u015eenormanc\u0131 \u00d6. Oxidative stress and inflammatory biomarkers in people with methamphetamine use disorder. Clin Psychopharmacol Neurosci. 2023;21:572\u201382.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"6018_CR37","doi-asserted-by":"publisher","first-page":"e13363","DOI":"10.1111\/adb.13363","volume":"29","author":"MH Ng","year":"2024","unstructured":"Ng MH, Lu ML, Chen VC, Ting H, Huang CL, Gossop M. Lymphocyte-related ratios in methamphetamine-induced psychotic disorder in Taiwan, comparing with patients with schizophrenia. Addict Biol. 2024;29:e13363.","journal-title":"Addict Biol"},{"key":"6018_CR38","first-page":"139","volume":"33","author":"MH Orum","year":"2020","unstructured":"Orum MH, Kara MZ. Monocyte to lymphocyte ratio and platelet to lymphocyte ratio in opioid users and marijuana users. Dusunen Adam J Psychiatry Neurol Sci. 2020;33:139\u201345.","journal-title":"Dusunen Adam J Psychiatry Neurol Sci"},{"key":"6018_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42238-019-0007-8","volume":"1","author":"O Alshaarawy","year":"2019","unstructured":"Alshaarawy O. Total and differential white blood cell count in cannabis users: results from the cross-sectional National Health and Nutrition Examination Survey, 2005\u20132016. J Cannabis Res. 2019;1:6.","journal-title":"J Cannabis Res"},{"key":"6018_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.9734\/acri\/2020\/v20i730212","volume":"20","author":"RA Amaechi","year":"2020","unstructured":"Amaechi RA, Babatope IO, Abulele PO. Obodo. Assessment of complete blood counts of cannabis sativa smokers in Ekpoma, Edo State, Nigeria. Archives Curr Res Int. 2020;20:38\u201348.","journal-title":"Archives Curr Res Int"},{"key":"6018_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.psychres.2017.02.028","volume":"251","author":"R McKetin","year":"2017","unstructured":"McKetin R, Baker AL, Dawe S, Voce A, Lubman DI. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. Psychiatry Res. 2017;251:349\u201354.","journal-title":"Psychiatry Res"},{"issue":"5","key":"6018_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cjca.2021.02.005","volume":"37","author":"PJ Connelly","year":"2021","unstructured":"Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to understand sex differences in cardiovascular disease. Can J Cardiol. 2021;37(5):699\u2013710.","journal-title":"Can J Cardiol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06018-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06018-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06018-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T13:07:47Z","timestamp":1724072867000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06018-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6018"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06018-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the F\u0131rat University Non-invasive Research Ethics Committee and the 1964 Declaration of Helsinki was complied with (Date: 01\/02\/2024; Number: 2024\/02\u201340). All respondents provided their consent for the information provided to be used for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}